Demographic details of patients treated with single dose ALA-PDT (PDT100), fractionated dose ALA-PDT (PDT20+100), or APC
| PDT100 (n = 13) | PDT20+100 (n = 13) | APC (n = 14) | |
|---|---|---|---|
| ALA, 5-aminolevulinic acid; APC, argon plasma coagulation; BO, Barrett’s oesophagus; LGD, low grade dysplasia; PDT, photodynamic therapy. | |||
| No significant differences between the groups. | |||
| Age (y) (median (range)) | 57 (52–72) | 61 (57–69) | 60 (41–69) |
| Sex (M/F) | 10/3 | 10/3 | 11/3 |
| BO length (cm) (median (range)) | 3 (2–5) | 3 (3–4) | 3 (3–4) |
| Histology of BO | |||
| No dysplasia | 10 | 11 | 1 |
| LGD | 3 | 2 | 3 |
| Follow up in months (median (range)) | 12 (9–18) | 12 (6–24) | 12 (9–21) |
| Mean dose of omeprazole (mg) (median (range)) | 46 (40–80) | 45 (40–80) | 51 (40–80) |